Igoumenou A, Turri M, Din R, Gordon H
BMJ Case Rep. 2011; 2009.
PMID: 22171235
PMC: 3029562.
DOI: 10.1136/bcr.04.2009.1736.
Eisenhofer G, Goldstein D, Kopin I, Crout J
Endocr Pathol. 2003; 14(3):193-212.
PMID: 14586065
DOI: 10.1007/s12022-003-0012-4.
LINDMAR R, Muscholl E
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964; 247:469-92.
PMID: 14254449
DOI: 10.1007/BF00329896.
CROUT J
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964; 248:85-98.
PMID: 14194528
DOI: 10.1007/BF00247061.
Bhagat B
Br J Pharmacol Chemother. 1964; 22:238-45.
PMID: 14190459
PMC: 1703988.
DOI: 10.1111/j.1476-5381.1964.tb02029.x.
[THE ALTERATION OF THE EFFECT OF TYRAMINE BY DIFFERENT SYMPATHICOMIMETICS IN RESERPINE-PRETREATED CATS].
GRAUBNER W, KOBINGER W
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1963; 246:175-83.
PMID: 14095444
DOI: 10.1007/BF00245003.
Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.
Pickar D, Cohen R, Jimerson D, Lake C, Murphy D
Psychopharmacology (Berl). 1981; 74(1):8-12.
PMID: 6791210
DOI: 10.1007/BF00431748.
Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.
Pickar D, Cohen R, Jimerson D, Murphy D
Psychopharmacology (Berl). 1981; 74(1):4-7.
PMID: 6791202
DOI: 10.1007/BF00431747.
Mechanism of cocaine potentiation of responses to amines.
Kalsner S, Nickerson M
Br J Pharmacol. 1969; 35(3):428-39.
PMID: 5809735
PMC: 1703361.
DOI: 10.1111/j.1476-5381.1969.tb08284.x.
Effects of reserpine on the disposition of sympathomimetic amines in vascular tissue.
Kalsner S, Nickerson M
Br J Pharmacol. 1969; 35(3):394-405.
PMID: 5809732
PMC: 1703358.
DOI: 10.1111/j.1476-5381.1969.tb08281.x.
Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.
Brodie B, Costa E, Groppetti A, Matsumoto C
Br J Pharmacol. 1968; 34(3):648-58.
PMID: 5726793
PMC: 1703529.
DOI: 10.1111/j.1476-5381.1968.tb08494.x.
Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs.
DeQuattro V, SJOERDSMA A
J Clin Invest. 1968; 47(10):2359-73.
PMID: 5676529
PMC: 297399.
DOI: 10.1172/JCI105920.
3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine?.
SHARMAN D, Tegerdine P
Br J Pharmacol. 1971; 42(3):343-51.
PMID: 5560896
PMC: 1665655.
DOI: 10.1111/j.1476-5381.1971.tb07118.x.
Human norepinephrine metabolism. Its evaluation bydministration of tritiated norepinephrine.
GITLOW S, MENDLOWITZ M, Bertani L, Wilk S, Wilkek
J Clin Invest. 1971; 50(4):859-65.
PMID: 5547279
PMC: 292000.
DOI: 10.1172/JCI106557.
The effects of carbon disulphide exposure on brain catecholamines in rats.
Magos L
Br J Pharmacol. 1970; 39(1):26-33.
PMID: 5420143
PMC: 1703024.
DOI: 10.1111/j.1476-5381.1970.tb09552.x.
Recent advances in the treatment of hypertension.
Smith W
Calif Med. 1966; 105(5):371-6.
PMID: 5334339
PMC: 1516570.
Effect of drugs on the synthesis of noradrenaline in guinea-pig vas deferens.
Boadle-Biber M, Roth R
Br J Pharmacol. 1972; 46(4):696-707.
PMID: 4655268
PMC: 1666369.
DOI: 10.1111/j.1476-5381.1972.tb06894.x.
Two types of 5-hydroxytryptamine release from isolated blood platelets.
BARTHOLINI G, Pletscher A
Experientia. 1964; 20(7):376-8.
PMID: 4379173
DOI: 10.1007/BF02147970.
Catecholamine-secreting tumours.
Sandler M
Proc R Soc Med. 1967; 60(8):795-7.
PMID: 4292418
PMC: 1901927.
Studies on the metabolism of catecholamines in the central nervous system of the mouse.
Ceasar P, HAGUE P, SHARMAN D, WERDINIUS B
Br J Pharmacol. 1974; 51(2):187-95.
PMID: 4141637
PMC: 1776743.
DOI: 10.1111/j.1476-5381.1974.tb09646.x.
